| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |





From the Departments of Internal Medicine,*
Surgery,
and
Pathology,
Kitasato Institute Medical Center
Hospital, Saitama; the Department of Internal
Medicine,
School of Medicine, Keio University,
Tokyo; and Lead Discovery Research Laboratories,¶
Sankyo Co., Ltd., Tokyo, Japan
Endothelin (ET) has been implicated in the regulation of hepatic microcirculation and development of portal hypertension. This study examined the localization of ETA receptor (ETAR) and ETB receptor (ETBR) in cirrhotic liver tissues from patients with hepatocellular carcinoma with hepatitis C-related cirrhosis, and normal liver samples from patients with metastatic liver carcinoma. Anti-ETAR and ETBR antibodies were used for immunohistochemistry and Western blot. Immunoelectron microscopy was conducted using immunoglobulin-gold and silver staining. For in situ hybridization (ISH), human ETAR and ETBR peptide nucleic acid probes were used with the catalyzed signal amplification system. In normal liver tissue, immunohistochemistry revealed that ETBR was predominantly expressed on hepatic sinusoidal lining cells, particularly on sinusoidal endothelial (SECs) and hepatic stellate cells (HSCs), and ETAR was scantily expressed. These findings were confirmed by Western blot and ISH. In cirrhotic liver tissue, overexpression of ETBR was demonstrated by Western blot and ISH. Morphometric analysis showed significant increase of ETBR expression on HSCs and SECs in cirrhotic liver, particularly on HSCs. ETAR expression was increased but remained low. Enhanced ETBR expression in cirrhosis may intensify the effect of endothelin on HSCs and increase hepatic microvascular tone.
This article has been cited by other articles:
![]() |
L. Tang, B. Luo, R. P. Patel, Y. Ling, J. Zhang, and M. B. Fallon Modulation of pulmonary endothelial endothelin B receptor expression and signaling: implications for experimental hepatopulmonary syndrome Am J Physiol Lung Cell Mol Physiol, June 1, 2007; 292(6): L1467 - L1472. [Abstract] [Full Text] [PDF] |
||||
![]() |
P W Angus Role of endothelin in systemic and portal resistance in cirrhosis. Gut, September 1, 2006; 55(9): 1230 - 1232. [Full Text] [PDF] |
||||
![]() |
D Tripathi, G Therapondos, J W Ferguson, D E Newby, D J Webb, and P C Hayes Endothelin-1 contributes to maintenance of systemic but not portal haemodynamics in patients with early cirrhosis: a randomised controlled trial Gut, September 1, 2006; 55(9): 1290 - 1295. [Abstract] [Full Text] [PDF] |
||||
![]() |
K Moore Endothelin and vascular function in liver disease Gut, February 1, 2004; 53(2): 159 - 161. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |